 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Stalevo 50.
No reviews have yet been submitted. Be the first to review this drug.
First Evidence for Long Term, Biologically Active Protein Expression in the Human Brain by Gene Therapy SAN DIEGO, May 17, 2012 /PRNewswire/ -- Ceregene...
Researchers have identified gene variants that speed the progression of Parkinson's disease, and they say their findings could help identify patients who would...
Vernalis plc today announces the successful outcome of its Phase I trial of V81444, its adenosine A2A antagonist with potential application in...
Looking for answers? Ask a question or go join the Stalevo 50 support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 16th, 2012), Cerner Multum™ (updated May 18th, 2012), Wolters Kluwer™ (updated Apr 29th, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
